Supplements for insulin resistance: what works according to research (ranking)

Insulin resistance rarely occurs alone. In a representative sample of 19,751 adult Poles, metabolic syndrome was found in 32.8% of women and 39% of men, with carbohydrate metabolism disorders contributing the most to the increase in this percentage over the decade (Rajca i wsp., 2021). The shelf of "sugar" preparations is growing faster than the evidence that would justify it. This review organizes the topic differently than a typical compilation: instead of promising an effect, it shows what exactly was measured, in whom, and for how many weeks. Here you will find an assessment of the strength of evidence for seven substances, warnings about interactions with medications, and the calculated cost per day of treatment for the products that the store actually has in stock.

KEY INFORMATION
• Magnesium reduced the HOMA-IR index by 0.67 points, but only after four months (Simental-Mendia i wsp., 2016).
• Berberine performed similarly to metformin in a pilot study with 36 participants; a meta-analysis of 14 studies did not confirm its superiority over medications.
• Myo-inositol has strong data only for polycystic ovary syndrome.
• Resveratrol works in people with diabetes; in others, it does not change anything.
• None of the products on this list replaces a medication prescribed by a doctor.

How was this ranking created and what does the strength of evidence mean?

There was one entry condition: at least one randomized controlled trial in which glycemia, fasting insulin, or HOMA-IR index was measured in humans. Results from cell cultures and animal models were not sufficient, even if the mechanism sounded convincing.

We describe the strength of evidence in three degrees. Strong means a meta-analysis of randomized studies that ended with a statistically significant result. Moderate refers to individual randomized studies that have not yet been compiled into a meta-analysis or whose results are inconsistent. Weak means that the effect is only visible in a narrow subgroup of patients or that instead of a clinical outcome, we only have an approved nutritional claim.

There are also three things that this review does not do. It does not evaluate brands or formulations, as the value of a product is determined by the standardization of the extract and the actual content of substances, not the name on the label. It does not place supplements alongside prescription medications as an equivalent therapeutic option, as publications that have made such comparisons were based on small samples. Finally, it does not replace diagnostics: insulin resistance is diagnosed from blood results, not from a list of symptoms read online.

Which supplements for insulin resistance have the strongest evidence?

The best-documented are magnesium and myo-inositol, as there are meta-analyses of randomized studies for both that ended with significant results. Berberine has the loudest numbers, but they come from small studies of low methodological quality. Cinnamon, chromium, alpha-lipoic acid, and resveratrol perform worse: they work under narrow conditions or only in people with diagnosed diabetes.

What do studies on berberine really show?

Berberine is an alkaloid from the root of barberry, and the most frequently cited work on it is a pilot study from 2008. Thirty-six people with recently diagnosed type 2 diabetes were randomly assigned to berberine 0.5 g three times a day or to metformin at the same dose. After three months, hemoglobin A1c dropped from 9.5% to 7.5%, and fasting glycemia from 10.6 to 6.9 mmol/l; the authors described the effect as similar to metformin (Yin i wsp., 2008). In the second part of the same study, in 48 people with poorly controlled diabetes, fasting insulin decreased by 28.1%, and HOMA-IR by 44.7%.

However, three caveats must be made. First, the authors themselves call their work a pilot study, and thirty-six people is too few to draw any conclusions. Second, a meta-analysis including 14 randomized studies and 1068 participants examined this comparison precisely, and berberine did not perform better than oral antidiabetic medications, and the methodological quality of the included studies was generally rated as low (Dong i wsp., 2012). Third, 34.5% of pilot participants experienced transient gastrointestinal discomfort.

The practical conclusion is clear and cannot be softened. Berberine is not a substitute for metformin, and the cited studies contain nothing that would justify discontinuing a medication prescribed by a doctor or delaying a visit.

Does myo-inositol help with PCOS and insulin resistance?

Yes, but the evidence pertains to one specific group. A systematic review from 2023 included 26 randomized studies and 1691 participants, of which 806 took inositol, 311 placebo, and 509 metformin. The chance of a regular menstrual cycle was 1.79 times higher with inositol than with placebo, and compared to metformin, inositol proved to be no worse (Greff i wsp., 2023). It also lowered glycemia, the area under the insulin curve, and testosterone levels compared to placebo.

Why polycystic ovary syndrome specifically? Myo-inositol acts as a secondary messenger of insulin signaling inside the cell, and in PCOS, a disturbance in its conversion to D-chiro-inositol has been described. Supplementation fills the missing link in the pathway, so the effect appears where there is actually something to supplement.

What do these data not tell us? They say nothing about men or women with insulin resistance without PCOS, as there were simply no such participants in the review. Transferring conclusions to other groups is an overinterpretation, although it frequently occurs in product descriptions. The u Bucha store does not have a product with myo-inositol as the main ingredient in its catalog, so if you are looking for it, read the label before buying anything described with the phrase "for insulin resistance."

How much do magnesium, cinnamon, and chromium actually provide?

Magnesium has the most data here. A meta-analysis of randomized studies showed a reduction in the HOMA-IR index by 0.67 points (95% confidence interval from -1.20 to -0.14; p = 0.013), while in the entire pool of studies, neither fasting glucose, glycated hemoglobin, nor insulin changed significantly (Simental-Mendia i wsp., 2016). The division into shorter and longer treatments shows where this variability comes from: a significant improvement in HOMA-IR and fasting glucose was only achieved with supplementation lasting at least four months.

Cinnamon was studied in the context of ordinary medical practice, making its results easier to translate into everyday life. In a randomized study involving 109 patients with type 2 diabetes and glycated hemoglobin above 7.0%, capsules containing 1 g of cinnamon daily for 90 days reduced HbA1c by 0.83%, compared to 0.37% in patients receiving only standard care (Crawford, 2009). The effect is real, but small. Additionally, with the cassia variety, there is the issue of coumarin, of which Ceylon cinnamon has negligible amounts.

Chromium performs the weakest among the three. In the European Union, a claim has been approved for it regarding its help in maintaining normal blood glucose levels (regulation 432/2012), but such a statement describes the role of the element in the body, not its effectiveness in treating insulin resistance. The reference intake value is 40 µg per day, and a typical preparation provides exactly that.

Is it worth adding resveratrol and alpha-lipoic acid?

The answer depends on whether you have already been diagnosed with diabetes. A meta-analysis of 11 randomized studies involving 388 people showed that resveratrol improves glycemic control and insulin sensitivity in people with diabetes, while in people without diabetes, it does not change any of the measured parameters (Liu i wsp., 2014). Subgroup analyses did not show any impact of dosage, duration of treatment, or body mass index. For someone with only insulin resistance, still without diabetes, this is rather discouraging.

Alpha-lipoic acid has more modest but consistent data. In a randomized study involving 57 patients with type 2 diabetes, a dose of 300 mg daily for 8 weeks reduced fasting glucose, postprandial glucose, and the HOMA-IR index compared to placebo (Ansar i wsp., 2011). Pay attention to the size of this dose, as labels often suggest two or four times more, citing studies that did not test such amounts.

None of these two substances are offered by the u Bucha store as single-ingredient preparations. If you are considering them, you are purchasing them outside of this catalog, and it is even more worthwhile to check the label for how much substance is in the daily serving, not just per capsule.

How much does a day of supplementation cost and what is available in the store?

The price alone says little, as a 15 ml bottle and a package of 180 capsules are completely different supplies. Therefore, in the last column, there is the cost of one daily serving, calculated from the manufacturer's declaration of serving size. Prices are sourced from the store's API, as of August 8, 2026.

It is also worth knowing what is not included in this comparison. The catalog does not contain a preparation with berberine or with myo-inositol as the leading ingredient; barberry appears only as one of the macerates in herbal blends. The extract from white mulberry is available in the store, but the manufacturer does not provide the size of the daily serving, so the cost of a day's treatment cannot be calculated fairly, which is why it did not make it to the table.

When can a supplement do more harm than good?

The most common mistake is combining a supplement with a medication that has the same mechanism. Berberine and metformin lower glucose in similar ways, so taken together, they can amplify the effect and lead to hypoglycemia. The same risk applies to combining with sulfonylurea derivatives and insulin. Such combinations are determined by the attending physician based on your results, not by an article on the internet.

Berberine also affects liver enzymes that metabolize drugs, which can alter the concentration of other medications taken regularly. If you are taking anything chronically, discussing it with a doctor or pharmacist is advisable before taking the first capsule, not after a month.

There are three situations in which supplementation is not the right tool. Pregnancy and breastfeeding, as most studies described here excluded these groups and there is simply no data. Kidney or liver disease, as the elimination of substances occurs differently then, and the doses from studies no longer apply. Diagnosed diabetes treated pharmacologically, as discontinuing medication in favor of an over-the-counter product is not supported by any of the studies cited in this article.

The fundamentals remain unchanged. Weight reduction, regular exercise, and a good night's sleep influence tissue sensitivity to insulin more than any substance on this list. A supplement added to a well-managed diet can be helpful; a supplement instead of a diet works against the odds.

Frequently Asked Questions

Can a supplement replace metformin or another prescription medication?

No. A meta-analysis of 14 randomized studies did not show that berberine provided better glycemic control than metformin, and the quality of the included studies was rated as generally low (Dong i wsp., 2012). Odstawienie leku przepisanego przez lekarza na rzecz suplementu nie ma oparcia w tych danych.

How long does it take to see the effects of supplementation?

It depends on the substance. For magnesium, a significant improvement in the HOMA-IR index was only achieved after a treatment lasting at least four months (Simental-Mendia i wsp., 2016). Cinnamon was studied for 90 days, and berberine for three months. An assessment after two weeks does not provide any conclusions, as measurements were taken much later.

Can berberine be combined with metformin?

Both substances lower glycemia through similar pathways, so their combination may amplify the effect and increase the risk of hypoglycemia. In a pilot study from 2008, berberine acted similarly to metformin administered at the same daily dose (Yin i wsp., 2008). Such a combination is determined by the attending physician, not the patient.

What dose of chromium makes sense for insulin resistance?

The reference intake value for chromium is 40 µg per day, which is provided by a typical supplement. In the European Union, a claim has been approved that chromium helps maintain normal blood glucose levels (regulation 432/2012). However, this is not evidence for treating insulin resistance with higher doses.

Does magnesium improve insulin sensitivity?

A meta-analysis of randomized studies showed a reduction in the HOMA-IR index by 0.67 points (Simental-Mendia i wsp., 2016). However, in the entire pool of studies, fasting glycemia and hemoglobin A1c did not change significantly. Improvement in HOMA-IR occurred with treatments longer than four months.

Does cinnamon from the kitchen cabinet work like a capsule?

In Crawford's study, capsules containing 1 g of cinnamon were used daily for 90 days, resulting in a decrease in hemoglobin A1c by 0.83% (Crawford, 2009). Sprinkling the spice by eye does not provide a repeatable dose, and the cassia variety contains coumarin, of which Ceylon cinnamon has negligible amounts.

You can check the composition and current prices of the products discussed in this overview in the category supplements, and herbal extracts in the category plant extracts.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-06-29 · Aktualizacja: 2026-08-08